Literature DB >> 16464222

Cryptogenic cirrhosis and NAFLD: are they related?

Anurag Maheshwari1, Paul J Thuluvath.   

Abstract

Cryptogenic cirrhosis (CC), literally meaning cirrhosis of obscure or unknown origin, is a diagnosis of exclusion. The circumstantial evidence indicates that nonalcoholic fatty liver disease (NAFLD) is perhaps one of the important causes of CC. There is also evidence, especially from the European literature, that some patients with CC may have undiagnosed or burnt-out autoimmune hepatitis (AIH). Other rare causes may include "unknown" viral (non-A, non-B, non-C) hepatitis, and occult alcoholism. In this review, we examine the role of NAFLD and other causes in the pathogenesis of CC, and the impact of obesity on patients with chronic liver disease.

Entities:  

Mesh:

Year:  2006        PMID: 16464222     DOI: 10.1111/j.1572-0241.2006.00478.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  19 in total

Review 1.  Cryptogenic cirrhosis: what are we missing?

Authors:  Stephen Caldwell
Journal:  Curr Gastroenterol Rep       Date:  2010-02

2.  Cryptogenic cirrhosis is the leading cause for listing for liver transplantation in Sri Lanka.

Authors:  R C Siriwardana; M A Niriella; C A H Liyanage; S R Wijesuriya; B Gunathilaka; A S Dassanayake; H J De Silva
Journal:  Indian J Gastroenterol       Date:  2013-09-03

3.  Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males.

Authors:  Wah-Kheong Chan; Norhaniza Bahar; Hamizah Razlan; Anushya Vijayananthan; Pavai Sithaneshwar; Khean-Lee Goh
Journal:  Hepatol Int       Date:  2014-01-03       Impact factor: 6.047

4.  Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients.

Authors:  Sanjiv Saigal; Nabeen C Nayak; Deepali Jain; Vinay Kumaran; Ravi Mohanka; Neeraj Saraf; Amit Rastogi; Naimesh Mehta; Samiran Nundy; Arvinder Soin
Journal:  Hepatol Int       Date:  2011-01-12       Impact factor: 6.047

Review 5.  Cryptogenic chronic hepatitis and its changing guise in adults.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

6.  The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes.

Authors:  A Sidney Barritt; Evan S Dellon; Tomasz Kozlowski; David A Gerber; Paul H Hayashi
Journal:  J Clin Gastroenterol       Date:  2011-04       Impact factor: 3.062

7.  Keratin 8 variants are associated with cryptogenic hepatitis.

Authors:  Mario Zierden; Arndt-Hendrik Penner; Manuel Montesinos-Rongen; Maren Weferling; Uta Drebber; Judith Stift; Jochen W U Fries; Margarete Odenthal; Stephan Rosenkranz; Hans-Peter Dienes
Journal:  Virchows Arch       Date:  2012-03-15       Impact factor: 4.064

8.  Methionine deficiency and hepatic injury in a dietary steatohepatitis model.

Authors:  Helieh S Oz; Theresa S Chen; Manuela Neuman
Journal:  Dig Dis Sci       Date:  2007-08-21       Impact factor: 3.199

9.  Trifluoroacetylated IgG4 antibodies in a child with idiosyncratic acute liver failure after first exposure to halothane.

Authors:  Christine Nguyen; Noel R Rose; Dolores B Njoku
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-08       Impact factor: 2.839

10.  Nonalcoholic fatty liver disease during valproate therapy.

Authors:  Alberto Verrotti; Giovanna Di Marco; Rosanna la Torre; Piernicola Pelliccia; Francesco Chiarelli
Journal:  Eur J Pediatr       Date:  2009-01-30       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.